Laminar Pharma

📍 Palma de Mallorca, Spain🗓 Founded 2006👥 40 employees💰 Last funded Dec 2022
Biotechnology Research🌐 laminarpharma.com
Website LinkedIn
Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the novel Membrane-Lipid Therapy (MLT) strategy, which targets membrane lipids and/or the structures they form, rather than directly targeting specific cellular proteins. MLT-based drugs specifically interact with and modulate the activity of key signal-transduction peripheral proteins involved in the pathogeny of serious diseases like cancer, CNS, inflammatory or metabolic diseases. Innovative MLT-based drugs will soon become reference treatments worldwide for serious diseases with important medical needs unmet, such as glioblastoma and other aggressive cancer malignancies, as well as neuro-degenerative, metabolic, cardiovascular or inflammatory diseases. These novel drugs will provide a safe and efficacious therapeutic alternative that will bring dramatic improvements in the clinical outcome and in the quality of life for an important number of patients with these pathologies.
3
Total investors
1
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Kuwait
1
Spain
1
Investor activity2006–2022 · investors recorded per year
200612020120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Laminar Pharma?
Laminar Pharma has 3 investors on record on gritt.io, including 1 early-stage backers.
When did Laminar Pharma last raise funding?
The most recent investment in Laminar Pharma recorded on gritt.io was in December 2022.
When was Laminar Pharma founded?
Laminar Pharma was founded in 2006.
What industry is Laminar Pharma in?
Laminar Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Laminar Pharma based?
Laminar Pharma is headquartered in Palma de Mallorca, Spain.